By otakuyassine3@gmail.com 
CVS Health Co. (NYSE:CVS – Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as $43.56 and last traded at $43.71, with a volume of 1630925 shares. The stock had previously closed at $44.36.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the stock. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $60.00 to $66.00 in a research note on Monday, November 18th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research note on Tuesday, December 3rd. Evercore ISI increased their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Truist Financial restated a “buy” rating and set a $67.00 price objective (down from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $69.12.
Read Our Latest Stock Analysis on CVS Health
CVS Health Stock Performance
The company has a market cap of $55.50 billion, a PE ratio of 11.19, a PEG ratio of 0.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The business has a 50-day moving average of $56.24 and a 200 day moving average of $58.23.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 EPS. Equities research analysts anticipate that CVS Health Co. will post 5.32 EPS for the current fiscal year.
Institutional Investors Weigh In On CVS Health
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Garland Capital Management Inc. raised its stake in shares of CVS Health by 0.3% in the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after buying an additional 160 shares during the period. Sound Income Strategies LLC boosted its position in shares of CVS Health by 7.2% in the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock worth $151,000 after purchasing an additional 162 shares during the period. Hexagon Capital Partners LLC increased its stake in shares of CVS Health by 3.5% in the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock worth $331,000 after purchasing an additional 178 shares in the last quarter. Bruce G. Allen Investments LLC lifted its stake in shares of CVS Health by 13.1% during the 3rd quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator’s stock valued at $106,000 after buying an additional 195 shares in the last quarter. Finally, HHM Wealth Advisors LLC boosted its holdings in CVS Health by 11.9% in the 2nd quarter. HHM Wealth Advisors LLC now owns 1,886 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 200 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
Receive News & Ratings for CVS Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health and related companies with MarketBeat.com’s FREE daily email newsletter.